Hosted by Agilent Cell Analysis

Event Details

With immune-based therapies emerging as a pillar for treating certain cancers, cell analysis is becoming a foundational science of the future. There is a need for robust cellular assays and workflows that meet the demands of immunotherapy and cell therapy discovery, engineering, process development, and manufacturing.

Our face-to-face Symposium events will explore this emerging field with a focus on cell engineering solutions, real-time, reporter-based assays, and automated workflows. These solutions, together with physiological cellular models, are actively being used for screening, characterization, and manufacturing of immunotherapies and cellular therapies. We’ll also review real-world examples of how these assays are being applied.

Key Learning Objectives:

• Discover how real-time cell analysis can be used to select and optimize chimeric antigen T (CAR-T) cells during discovery, method development, and manufacturing.
• Understand how to use emerging microplate reading and cellular imaging technologies to perform robust, reliable antibody-dependent and cell-mediated cytotoxicity assays.
• Explore techniques for gaining unique insights into the critical drivers behind immune cell function—and improving T cell persistence and antitumor potency.

Coming to a City Near You

Recent Events